EWA
MYGN icon

EverSource Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

EverSource Wealth Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Sell
2,645
-7,671
-74% -$34.8K ﹤0.01% 2646
2026
Q1 		$46.4K Sell
10,316
-153
-1% -$797 ﹤0.01% 1947
2025
Q4 		$64.4K Buy
10,469
+6,097
+139% +$44.2K ﹤0.01% 1578
2025
Q3 		$31.6K Sell
4,372
-300
-6% -$1.78K ﹤0.01% 2025
2025
Q2 		$24.8K Buy
4,672
+4,480
+2,333% +$26.5K ﹤0.01% 2132
2025
Q1 		$1.7K Sell
192
-165
-46% -$1.98K ﹤0.01% 2993
2024
Q4 		$4.89K Sell
357
-124
-26% -$2.29K ﹤0.01% 2361
2024
Q3 		$13.2K Hold
481
– – ﹤0.01% 1714
2024
Q2 		$13.5K Buy
481
+13
+3% +$285 ﹤0.01% 1704
2024
Q1 		$9.16K Buy
468
+5
+1% +$107 ﹤0.01% 1735
2023
Q4 		$8.86K Buy
463
+241
+109% +$4.17K ﹤0.01% 1615
2023
Q3 		$3.56K Sell
222
-645
-74% -$12.3K ﹤0.01% 1827
2023
Q2 		$20.1K Buy
867
+155
+22% +$3.38K ﹤0.01% 1150
2023
Q1 		$16.5K Buy
712
+273
+62% +$5.54K ﹤0.01% 1153
2022
Q4 		$6.37K Sell
439
-69
-14% -$1.29K ﹤0.01% 1506
2022
Q3 		$9K Buy
+508
New +$11.7K ﹤0.01% 1158

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EverSource Wealth Advisors's MYGN Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Myriad Genetics (MYGN) stake by 74% in Q2 2026, selling an estimated $34.8K and leaving 2,645 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

EverSource Wealth Advisors first reported a position in MYGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $64.4K in Q4 2025. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • EverSource Wealth Advisors held 2,645 shares of Myriad Genetics worth $15.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 7,671 Myriad Genetics shares in Q2 2026, an estimated $34.8K.
  • Myriad Genetics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2646 holding.
  • EverSource Wealth Advisors first reported a position in Myriad Genetics in Q3 2022 and has held it in 16 quarters since.
  • EverSource Wealth Advisors's Myriad Genetics position peaked at $64.4K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.